Although no study aimed to investigate the contribution of Abcg1 in non-alcoholic steatohepatitis (NASH) and more widely in fatty liver diseases (NAFLD) has been conducted, several lines of evidence indicate that Abcg1 plays an important role in lipid homeostasis in the liver. Here, ABCG1 is linked to metabolic dysfunction-associated steatotic liver disease.